DENTSPLY SIRONA Inc. (XRAY) 10-Year Financial Performance & Capital Metrics

XRAY • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesSafety Syringes & Injectables

AboutDENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.Show more

Revenue $3.79B -4.3%
EBITDA -$530M -305.4%
Net Income -$910M -589.4%
EPS (Diluted) -4.48 -622.6%
Gross Margin 51.62% -1.9%
EBITDA Margin -13.97% -314.7%
Operating Margin -23.17% -981.0%
Net Margin -23.99% -620.7%
ROE -34.75% -835.4%
ROIC -14.33% -1119.6%
Debt/Equity 1.17 +67.5%
Interest Coverage -12.74 -1114.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓22 consecutive years of dividend growth
✓Healthy dividend yield of 4.9%
✓Share count reduced 4.2% through buybacks
✓Trading at only 1.3x book value

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.64%

5Y-1.17%

3Y-3.58%

TTM-7.08%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-113.56%

EPS CAGR

10Y-

5Y-

3Y-

TTM-114.06%

ROCE

10Y Avg-3.07%

5Y Avg-4.83%

3Y Avg-10.58%

Latest-17.39%

Peer Comparison

Safety Syringes & Injectables

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UTMDUtah Medical Products, Inc.	193.09M	60.27	15.22	-18.56%	32.33%	10.68%	7.56%	0.00
STSSSharps Technology, Inc.	66.69M	2.30	-0.00		-324.78%	-4.98%		1.89
RVPRetractable Technologies, Inc.	21.26M	0.71	-1.78	-24.19%	-22.9%	-11.43%		0.01
XRAYDENTSPLY SIRONA Inc.	2.51B	12.58	-2.81	-4.34%	-24.34%	-59.68%	11.19%	1.17
ZTEKZentek Ltd.	93.36M	0.87	-8.70	28.26%	-8.95%	-70.13%		0.05

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.67B	3.75B	3.99B	3.99B	4.02B	3.34B	4.23B	3.92B	3.96B	3.79B
Revenue Growth %	-0.08%	0.4%	0.07%	-0%	0.01%	-0.17%	0.27%	-0.07%	0.01%	-0.04%
Cost of Goods Sold+	1.16B	1.74B	1.8B	1.92B	1.86B	1.68B	1.88B	1.79B	1.88B	1.83B
COGS % of Revenue	0.43%	0.47%	0.45%	0.48%	0.46%	0.5%	0.45%	0.46%	0.47%	0.48%
Gross Profit+	1.52B	2B	2.19B	2.07B	2.16B	1.66B	2.35B	2.13B	2.09B	1.96B
Gross Margin %	0.57%	0.53%	0.55%	0.52%	0.54%	0.5%	0.55%	0.54%	0.53%	0.52%
Gross Profit Growth %	-0.05%	0.32%	0.09%	-0.06%	0.05%	-0.23%	0.42%	-0.09%	-0.02%	-0.06%
Operating Expenses+	1.08B	1.52B	1.67B	1.72B	1.81B	1.66B	1.74B	3.06B	2.17B	2.84B
OpEx % of Revenue	0.4%	0.41%	0.42%	0.43%	0.45%	0.5%	0.41%	0.78%	0.55%	0.75%
Selling, General & Admin	1.08B	1.52B	1.67B	1.72B	1.59B	1.3B	1.55B	1.59B	1.61B	1.6B
SG&A % of Revenue	0.4%	0.41%	0.42%	0.43%	0.39%	0.39%	0.37%	0.41%	0.41%	0.42%
Research & Development	74.9M	128.5M	151.7M	160.5M	143M	123M	171M	174M	184M	165M
R&D % of Revenue	0.03%	0.03%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.05%	0.04%
Other Operating Expenses	81.2M	44.1M	2.07B	1.33B	81M	234M	17M	1.3B	374M	1.07B
Operating Income+	375.2M	454.7M	-1.59B	-958.1M	353M	-3M	608M	-937M	-85M	-879M
Operating Margin %	0.14%	0.12%	-0.4%	-0.24%	0.09%	-0%	0.14%	-0.24%	-0.02%	-0.23%
Operating Income Growth %	-0.16%	0.21%	-4.49%	0.4%	1.37%	-1.01%	203.67%	-2.54%	0.91%	-9.34%
EBITDA+	498.1M	726.4M	-1.27B	-627.3M	676M	331M	954M	-609M	258M	-530M
EBITDA Margin %	0.19%	0.19%	-0.32%	-0.16%	0.17%	0.1%	0.23%	-0.16%	0.07%	-0.14%
EBITDA Growth %	-0.13%	0.46%	-2.75%	0.51%	2.08%	-0.51%	1.88%	-1.64%	1.42%	-3.05%
D&A (Non-Cash Add-back)	122.9M	271.7M	316.4M	330.8M	323M	334M	346M	328M	343M	349M
EBIT	385.6M	476.8M	-1.57B	-921M	365M	-4M	606M	-990M	-94M	-867M
Net Interest Income+	-53.7M	-33.9M	-35.9M	-35M	-27M	-61M	-61M	-65M	-81M	-69M
Interest Income	2.2M	2M	2.4M	2.1M	2.4M	1M	0	0	0	0
Interest Expense	55.9M	35.9M	38.3M	37.3M	29.4M	62M	61M	65M	81M	69M
Other Income/Expense	-45.5M	-13.8M	-41.2M	-400K	-15M	-47M	-63M	-118M	-90M	-57M
Pretax Income+	329.7M	440.9M	-1.63B	-958.4M	338M	-50M	545M	-1.05B	-175M	-936M
Pretax Margin %	0.12%	0.12%	-0.41%	-0.24%	0.08%	-0.01%	0.13%	-0.27%	-0.04%	-0.25%
Income Tax+	77M	9.5M	-53.2M	52.5M	82M	23M	134M	-105M	-43M	-26M
Effective Tax Rate %	0.76%	0.98%	0.95%	1.05%	0.76%	1.46%	0.75%	0.9%	0.75%	0.97%
Net Income+	251.2M	429.9M	-1.55B	-1.01B	256M	-73M	411M	-950M	-132M	-910M
Net Margin %	0.09%	0.11%	-0.39%	-0.25%	0.06%	-0.02%	0.1%	-0.24%	-0.03%	-0.24%
Net Income Growth %	-0.22%	0.71%	-4.61%	0.35%	1.25%	-1.29%	6.63%	-3.31%	0.86%	-5.89%
Net Income (Continuing)	251.1M	431.4M	-1.55B	-1.01B	256M	-73M	411M	-950M	-132M	-910M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	1.4M	11.6M	11.6M	11.9M	2M	3M	1M	1M	1M	1M
EPS (Diluted)+	1.76	1.94	-6.86	-4.51	1.17	-0.38	1.87	-4.41	-0.62	-4.48
EPS Growth %	-0.21%	0.1%	-4.54%	0.34%	1.26%	-1.32%	5.92%	-3.36%	0.86%	-6.23%
EPS (Basic)	1.79	1.97	-6.86	-4.51	1.18	-0.38	1.88	-4.41	-0.62	-4.48
Diluted Shares Outstanding	142.5M	221.6M	229.4M	224.3M	224.4M	219.2M	220.2M	215.5M	212M	203.2M
Basic Shares Outstanding	140M	218M	229.29M	224.17M	223.1M	219.2M	218.4M	215.5M	212M	203.2M
Dividend Payout Ratio	0.16%	0.15%	-	-	0.32%	-	0.22%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.2B	1.88B	2B	1.89B	2B	1.8B	1.85B	1.89B	1.97B	1.75B
Cash & Short-Term Investments	284.6M	383.9M	320.6M	309.6M	405M	438M	339M	365M	334M	272M
Cash Only	284.6M	383.9M	320.6M	309.6M	405M	438M	339M	365M	334M	272M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	399.9M	636M	746.2M	701.9M	828M	706M	803M	685M	756M	606M
Days Sales Outstanding	54.58	61.98	68.2	64.27	75.14	77.18	69.27	63.75	69.59	58.32
Inventory	340.4M	517.1M	623.1M	598.9M	562M	476M	515M	627M	624M	564M
Days Inventory Outstanding	107.38	108.2	126.01	113.94	110.4	103.23	99.77	127.5	121.21	112.19
Other Current Assets	132.9M	122.9M	120.7M	172.8M	84M	67M	84M	88M	146M	153M
Total Non-Current Assets+	3.21B	9.77B	8.38B	6.8B	6.6B	7.55B	7.39B	5.75B	5.4B	4.01B
Property, Plant & Equipment	558.8M	799.8M	876M	870.6M	961M	967M	971M	961M	978M	902M
Fixed Asset Turnover	4.79x	4.68x	4.56x	4.58x	4.19x	3.45x	4.36x	4.08x	4.05x	4.21x
Goodwill	1.99B	5.95B	4.52B	3.43B	3.4B	3.99B	3.98B	2.69B	2.44B	1.6B
Intangible Assets	600.7M	2.96B	2.83B	2.42B	2.18B	2.5B	2.32B	1.9B	1.71B	1.21B
Long-Term Investments	-160.3M	-848.6M	-718M	-552.8M	0	0	0	0	0	23M
Other Non-Current Assets	59.1M	64.1M	156.2M	76.8M	69M	95M	121M	198M	48M	278M
Total Assets+	4.4B	11.66B	10.38B	8.69B	8.6B	9.35B	9.24B	7.64B	7.37B	5.75B
Asset Turnover	0.61x	0.32x	0.38x	0.46x	0.47x	0.36x	0.46x	0.51x	0.54x	0.66x
Asset Growth %	-0.05%	1.65%	-0.11%	-0.16%	-0.01%	0.09%	-0.01%	-0.17%	-0.04%	-0.22%
Total Current Liabilities+	476M	771M	946.6M	1.01B	995M	1.37B	1.26B	1.17B	1.43B	1.59B
Accounts Payable	133.6M	223M	284.4M	283.9M	308M	302M	262M	279M	305M	241M
Days Payables Outstanding	42.14	46.66	57.51	54.01	60.51	65.5	50.76	56.73	59.25	47.94
Short-Term Debt	12.1M	21.1M	30.1M	92.4M	2M	299M	182M	118M	322M	549M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	166.9M	260.1M	353.3M	339.1M	128M	166M	212M	182M	458M	64M
Current Ratio	2.51x	2.44x	2.12x	1.86x	2.01x	1.31x	1.47x	1.62x	1.38x	1.10x
Quick Ratio	1.80x	1.77x	1.46x	1.27x	1.45x	0.96x	1.06x	1.08x	0.95x	0.74x
Cash Conversion Cycle	119.81	123.52	136.7	124.2	125.04	114.91	118.29	134.51	131.56	122.56
Total Non-Current Liabilities+	1.59B	2.76B	2.79B	2.54B	2.51B	3.04B	2.98B	2.66B	2.65B	2.22B
Long-Term Debt	1.14B	1.51B	1.61B	1.56B	1.43B	1.98B	1.91B	1.83B	1.8B	1.59B
Capital Lease Obligations	0	0	0	0	120M	130M	149M	149M	125M	91M
Deferred Tax Liabilities	160.3M	848.6M	718M	552.8M	480M	381M	391M	287M	0	129M
Other Non-Current Liabilities	446.5M	1.25B	1.18B	975.8M	480M	554M	528M	399M	730M	415M
Total Liabilities	2.06B	3.53B	3.74B	3.55B	3.51B	4.42B	4.24B	3.83B	4.08B	3.81B
Total Debt+	1.14B	1.51B	1.61B	1.66B	1.6B	2.46B	2.29B	2.15B	2.3B	2.27B
Net Debt	856.4M	1.13B	1.29B	1.35B	1.19B	2.02B	1.96B	1.78B	1.97B	2B
Debt / Equity	0.49x	0.19x	0.24x	0.32x	0.31x	0.50x	0.46x	0.56x	0.70x	1.17x
Debt / EBITDA	2.29x	2.08x	-	-	2.37x	7.42x	2.40x	-	8.91x	-
Net Debt / EBITDA	1.72x	1.55x	-	-	1.77x	6.09x	2.05x	-	7.62x	-
Interest Coverage	6.71x	12.67x	-41.39x	-25.69x	12.01x	-0.05x	9.97x	-14.42x	-1.05x	-12.74x
Total Equity+	2.34B	8.13B	6.64B	5.13B	5.09B	4.93B	5B	3.81B	3.29B	1.94B
Equity Growth %	0.01%	2.47%	-0.18%	-0.23%	-0.01%	-0.03%	0.01%	-0.24%	-0.14%	-0.41%
Book Value per Share	16.42	36.67	28.95	22.88	22.70	22.51	22.69	17.69	15.54	9.56
Total Shareholders' Equity	2.34B	8.11B	6.63B	5.12B	5.09B	4.93B	5B	3.81B	3.29B	1.94B
Common Stock	1.6M	2.6M	2.6M	2.6M	3M	3M	3M	3M	3M	3M
Retained Earnings	3.59B	3.95B	2.32B	1.23B	1.4B	1.2B	1.51B	456M	205M	-835M
Treasury Stock	-898.4M	-1.65B	-1.96B	-2.15B	-2.3B	-2.41B	-2.54B	-2.65B	-2.92B	-3.14B
Accumulated OCI	-594M	-705.7M	-291M	-478.7M	-600M	-464M	-592M	-628M	-636M	-730M
Minority Interest	1.4M	11.6M	11.6M	11.9M	2M	3M	1M	1M	1M	1M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	497.4M	563.4M	601.9M	499.8M	632.8M	649M	657M	517M	377M	461M
Operating CF Margin %	0.19%	0.15%	0.15%	0.13%	0.16%	0.19%	0.16%	0.13%	0.1%	0.12%
Operating CF Growth %	-0.11%	0.13%	0.07%	-0.17%	0.27%	0.03%	0.01%	-0.21%	-0.27%	0.22%
Net Income	251.1M	431.4M	-1.57B	-1.01B	263.1M	-73M	411M	-950M	-132M	-910M
Depreciation & Amortization	122.9M	271.7M	316.4M	330.8M	322.8M	334M	346M	328M	343M	349M
Stock-Based Compensation	25.6M	41.3M	48M	21M	66.2M	47M	48M	59M	46M	39M
Deferred Taxes	15.8M	-110.1M	-143.8M	-62M	-37.4M	-62M	-25M	-228M	-130M	-136M
Other Non-Cash Items	43.9M	-15M	2.08B	1.26B	50M	203M	3M	1.39B	339M	1.02B
Working Capital Changes	38.1M	-43.2M	-144.8M	-33.2M	-19.8M	200M	-126M	-78M	-89M	95M
Change in Receivables	-900K	-75.1M	-63.4M	23.5M	-91.4M	131M	-117M	85M	-58M	104M
Change in Inventory	32.1M	65.4M	-62.9M	-19.9M	13.7M	123M	-64M	-141M	6M	17M
Change in Payables	8.8M	7.2M	44.2M	7.1M	26.1M	-28M	-49M	30M	14M	-30M
Cash from Investing+	-54.9M	60M	-286.4M	-253.3M	-68.4M	-1.11B	-358M	-138M	-89M	-197M
Capital Expenditures	-72M	-126.1M	-151M	-188M	-122.9M	-87M	-142M	-149M	-149M	-180M
CapEx % of Revenue	0.03%	0.03%	0.04%	0.05%	0.03%	0.03%	0.03%	0.04%	0.04%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-105.8M	399.5M	-144.5M	-179.3M	-117M	1M	2M	-2M	47M	-17M
Cash from Financing+	-302.9M	-526.2M	-400.8M	-249.8M	-466.1M	476M	-379M	-329M	-307M	-302M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-40M	-64.6M	-78.3M	-78.6M	-80.9M	-88M	-92M	-104M	-116M	-126M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-33.4M	53.3M	82.3M	27.8M	75.6M	43M	15M	-15M	-10M	-16M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	425.4M	437.3M	450.9M	311.8M	509.9M	562M	515M	368M	228M	281M
FCF Margin %	0.16%	0.12%	0.11%	0.08%	0.13%	0.17%	0.12%	0.09%	0.06%	0.07%
FCF Growth %	-0.06%	0.03%	0.03%	-0.31%	0.64%	0.1%	-0.08%	-0.29%	-0.38%	0.23%
FCF per Share	2.99	1.97	1.97	1.39	2.27	2.56	2.34	1.71	1.08	1.38
FCF Conversion (FCF/Net Income)	1.98x	1.31x	-0.39x	-0.49x	2.47x	-8.89x	1.60x	-0.54x	-2.86x	-0.51x
Interest Paid	54.9M	36.7M	37M	35M	30M	45M	64M	70M	97M	91M
Taxes Paid	-71.4M	112.3M	122.7M	105M	112M	82M	148M	122M	177M	74M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.78%	8.22%	-20.99%	-17.17%	5.01%	-1.46%	8.28%	-21.57%	-3.72%	-34.75%
Return on Invested Capital (ROIC)	8.63%	5.48%	-13.84%	-9.97%	4.15%	-0.03%	6.56%	-11.2%	-1.17%	-14.33%
Gross Margin	56.73%	53.42%	54.8%	51.87%	53.8%	49.6%	55.47%	54.23%	52.61%	51.62%
Net Margin	9.39%	11.48%	-38.81%	-25.36%	6.37%	-2.19%	9.71%	-24.22%	-3.33%	-23.99%
Debt / Equity	0.49x	0.19x	0.24x	0.32x	0.31x	0.50x	0.46x	0.56x	0.70x	1.17x
Interest Coverage	6.71x	12.67x	-41.39x	-25.69x	12.01x	-0.05x	9.97x	-14.42x	-1.05x	-12.74x
FCF Conversion	1.98x	1.31x	-0.39x	-0.49x	2.47x	-8.89x	1.60x	-0.54x	-2.86x	-0.51x
Revenue Growth	-8.5%	40.05%	6.62%	-0.18%	0.9%	-16.98%	26.71%	-7.3%	1.1%	-4.34%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Technologies And Equipment	-	-	2.2B	2.14B	2.28B	1.96B	2.52B	2.32B	-	-
Technologies And Equipment Growth	-	-	-	-2.96%	6.91%	-14.11%	28.71%	-8.16%	-	-
Consumables	-	-	1.79B	1.85B	1.75B	1.38B	1.73B	1.6B	-	-
Consumables Growth	-	-	-	3.24%	-5.66%	-20.90%	25.05%	-7.12%	-	-
Dental Consumable Products	751.5M	1.77B	-	-	-	-	-	-	-	-
Dental Consumable Products Growth	-	135.57%	-	-	-	-	-	-	-	-
Dental Laboratory Products	333.7M	1.66B	-	-	-	-	-	-	-	-
Dental Laboratory Products Growth	-	397.03%	-	-	-	-	-	-	-	-
Dental Speciality Products	1.27B	316.4M	-	-	-	-	-	-	-	-
Dental Speciality Products Growth	-	-75.16%	-	-	-	-	-	-	-	-
Consumable medical device products	315.5M	-	-	-	-	-	-	-	-	-
Consumable medical device products Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Europe	-	-	-	-	1.61B	1.39B	1.69B	1.56B	1.55B	1.52B
Europe Growth	-	-	-	-	-	-14.06%	21.49%	-7.48%	-0.58%	-2.06%
UNITED STATES	1.03B	1.38B	1.38B	1.27B	1.37B	1.11B	1.5B	1.39B	1.44B	1.35B
UNITED STATES Growth	-	34.61%	-0.47%	-7.74%	8.12%	-19.23%	34.99%	-7.01%	3.23%	-6.19%
Other Foreign	-	-	-	-	1.04B	846M	1.07B	971M	978M	927M
Other Foreign Growth	-	-	-	-	-	-18.81%	26.36%	-9.17%	0.72%	-5.21%
GERMANY	472.8M	617M	493.3M	494.3M	-	-	-	-	-	-
GERMANY Growth	-	30.50%	-20.05%	0.20%	-	-	-	-	-	-
SWEDEN	42.3M	53.2M	52.4M	55.2M	-	-	-	-	-	-
SWEDEN Growth	-	25.77%	-1.50%	5.34%	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

DENTSPLY SIRONA Inc. (XRAY) reported $3.62B in revenue for fiscal year 2024. This represents a 43% increase from $2.54B in 2011.

DENTSPLY SIRONA Inc. (XRAY) saw revenue decline by 4.3% over the past year.

DENTSPLY SIRONA Inc. (XRAY) reported a net loss of $882.0M for fiscal year 2024.

Dividend & Returns

Yes, DENTSPLY SIRONA Inc. (XRAY) pays a dividend with a yield of 4.93%. This makes it attractive for income-focused investors.

DENTSPLY SIRONA Inc. (XRAY) has a return on equity (ROE) of -34.8%. Negative ROE indicates the company is unprofitable.

DENTSPLY SIRONA Inc. (XRAY) generated $80.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

DENTSPLY SIRONA Inc. (XRAY) 10-Year Financial Performance & Capital Metrics

XRAY • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesSafety Syringes & Injectables

Revenue $3.79B -4.3%
EBITDA -$530M -305.4%
Net Income -$910M -589.4%
EPS (Diluted) -4.48 -622.6%
Gross Margin 51.62% -1.9%
EBITDA Margin -13.97% -314.7%
Operating Margin -23.17% -981.0%
Net Margin -23.99% -620.7%
ROE -34.75% -835.4%
ROIC -14.33% -1119.6%
Debt/Equity 1.17 +67.5%
Interest Coverage -12.74 -1114.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓22 consecutive years of dividend growth
✓Healthy dividend yield of 4.9%
✓Share count reduced 4.2% through buybacks
✓Trading at only 1.3x book value

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.64%

5Y-1.17%

3Y-3.58%

TTM-7.08%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-113.56%

EPS CAGR

10Y-

5Y-

3Y-

TTM-114.06%

ROCE

10Y Avg-3.07%

5Y Avg-4.83%

3Y Avg-10.58%

Latest-17.39%

Peer Comparison

Safety Syringes & Injectables

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UTMDUtah Medical Products, Inc.	193.09M	60.27	15.22	-18.56%	32.33%	10.68%	7.56%	0.00
STSSSharps Technology, Inc.	66.69M	2.30	-0.00		-324.78%	-4.98%		1.89
RVPRetractable Technologies, Inc.	21.26M	0.71	-1.78	-24.19%	-22.9%	-11.43%		0.01
XRAYDENTSPLY SIRONA Inc.	2.51B	12.58	-2.81	-4.34%	-24.34%	-59.68%	11.19%	1.17
ZTEKZentek Ltd.	93.36M	0.87	-8.70	28.26%	-8.95%	-70.13%		0.05

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.67B	3.75B	3.99B	3.99B	4.02B	3.34B	4.23B	3.92B	3.96B	3.79B
Revenue Growth %	-0.08%	0.4%	0.07%	-0%	0.01%	-0.17%	0.27%	-0.07%	0.01%	-0.04%
Cost of Goods Sold+	1.16B	1.74B	1.8B	1.92B	1.86B	1.68B	1.88B	1.79B	1.88B	1.83B
COGS % of Revenue	0.43%	0.47%	0.45%	0.48%	0.46%	0.5%	0.45%	0.46%	0.47%	0.48%
Gross Profit+	1.52B	2B	2.19B	2.07B	2.16B	1.66B	2.35B	2.13B	2.09B	1.96B
Gross Margin %	0.57%	0.53%	0.55%	0.52%	0.54%	0.5%	0.55%	0.54%	0.53%	0.52%
Gross Profit Growth %	-0.05%	0.32%	0.09%	-0.06%	0.05%	-0.23%	0.42%	-0.09%	-0.02%	-0.06%
Operating Expenses+	1.08B	1.52B	1.67B	1.72B	1.81B	1.66B	1.74B	3.06B	2.17B	2.84B
OpEx % of Revenue	0.4%	0.41%	0.42%	0.43%	0.45%	0.5%	0.41%	0.78%	0.55%	0.75%
Selling, General & Admin	1.08B	1.52B	1.67B	1.72B	1.59B	1.3B	1.55B	1.59B	1.61B	1.6B
SG&A % of Revenue	0.4%	0.41%	0.42%	0.43%	0.39%	0.39%	0.37%	0.41%	0.41%	0.42%
Research & Development	74.9M	128.5M	151.7M	160.5M	143M	123M	171M	174M	184M	165M
R&D % of Revenue	0.03%	0.03%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.05%	0.04%
Other Operating Expenses	81.2M	44.1M	2.07B	1.33B	81M	234M	17M	1.3B	374M	1.07B
Operating Income+	375.2M	454.7M	-1.59B	-958.1M	353M	-3M	608M	-937M	-85M	-879M
Operating Margin %	0.14%	0.12%	-0.4%	-0.24%	0.09%	-0%	0.14%	-0.24%	-0.02%	-0.23%
Operating Income Growth %	-0.16%	0.21%	-4.49%	0.4%	1.37%	-1.01%	203.67%	-2.54%	0.91%	-9.34%
EBITDA+	498.1M	726.4M	-1.27B	-627.3M	676M	331M	954M	-609M	258M	-530M
EBITDA Margin %	0.19%	0.19%	-0.32%	-0.16%	0.17%	0.1%	0.23%	-0.16%	0.07%	-0.14%
EBITDA Growth %	-0.13%	0.46%	-2.75%	0.51%	2.08%	-0.51%	1.88%	-1.64%	1.42%	-3.05%
D&A (Non-Cash Add-back)	122.9M	271.7M	316.4M	330.8M	323M	334M	346M	328M	343M	349M
EBIT	385.6M	476.8M	-1.57B	-921M	365M	-4M	606M	-990M	-94M	-867M
Net Interest Income+	-53.7M	-33.9M	-35.9M	-35M	-27M	-61M	-61M	-65M	-81M	-69M
Interest Income	2.2M	2M	2.4M	2.1M	2.4M	1M	0	0	0	0
Interest Expense	55.9M	35.9M	38.3M	37.3M	29.4M	62M	61M	65M	81M	69M
Other Income/Expense	-45.5M	-13.8M	-41.2M	-400K	-15M	-47M	-63M	-118M	-90M	-57M
Pretax Income+	329.7M	440.9M	-1.63B	-958.4M	338M	-50M	545M	-1.05B	-175M	-936M
Pretax Margin %	0.12%	0.12%	-0.41%	-0.24%	0.08%	-0.01%	0.13%	-0.27%	-0.04%	-0.25%
Income Tax+	77M	9.5M	-53.2M	52.5M	82M	23M	134M	-105M	-43M	-26M
Effective Tax Rate %	0.76%	0.98%	0.95%	1.05%	0.76%	1.46%	0.75%	0.9%	0.75%	0.97%
Net Income+	251.2M	429.9M	-1.55B	-1.01B	256M	-73M	411M	-950M	-132M	-910M
Net Margin %	0.09%	0.11%	-0.39%	-0.25%	0.06%	-0.02%	0.1%	-0.24%	-0.03%	-0.24%
Net Income Growth %	-0.22%	0.71%	-4.61%	0.35%	1.25%	-1.29%	6.63%	-3.31%	0.86%	-5.89%
Net Income (Continuing)	251.1M	431.4M	-1.55B	-1.01B	256M	-73M	411M	-950M	-132M	-910M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	1.4M	11.6M	11.6M	11.9M	2M	3M	1M	1M	1M	1M
EPS (Diluted)+	1.76	1.94	-6.86	-4.51	1.17	-0.38	1.87	-4.41	-0.62	-4.48
EPS Growth %	-0.21%	0.1%	-4.54%	0.34%	1.26%	-1.32%	5.92%	-3.36%	0.86%	-6.23%
EPS (Basic)	1.79	1.97	-6.86	-4.51	1.18	-0.38	1.88	-4.41	-0.62	-4.48
Diluted Shares Outstanding	142.5M	221.6M	229.4M	224.3M	224.4M	219.2M	220.2M	215.5M	212M	203.2M
Basic Shares Outstanding	140M	218M	229.29M	224.17M	223.1M	219.2M	218.4M	215.5M	212M	203.2M
Dividend Payout Ratio	0.16%	0.15%	-	-	0.32%	-	0.22%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.2B	1.88B	2B	1.89B	2B	1.8B	1.85B	1.89B	1.97B	1.75B
Cash & Short-Term Investments	284.6M	383.9M	320.6M	309.6M	405M	438M	339M	365M	334M	272M
Cash Only	284.6M	383.9M	320.6M	309.6M	405M	438M	339M	365M	334M	272M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	399.9M	636M	746.2M	701.9M	828M	706M	803M	685M	756M	606M
Days Sales Outstanding	54.58	61.98	68.2	64.27	75.14	77.18	69.27	63.75	69.59	58.32
Inventory	340.4M	517.1M	623.1M	598.9M	562M	476M	515M	627M	624M	564M
Days Inventory Outstanding	107.38	108.2	126.01	113.94	110.4	103.23	99.77	127.5	121.21	112.19
Other Current Assets	132.9M	122.9M	120.7M	172.8M	84M	67M	84M	88M	146M	153M
Total Non-Current Assets+	3.21B	9.77B	8.38B	6.8B	6.6B	7.55B	7.39B	5.75B	5.4B	4.01B
Property, Plant & Equipment	558.8M	799.8M	876M	870.6M	961M	967M	971M	961M	978M	902M
Fixed Asset Turnover	4.79x	4.68x	4.56x	4.58x	4.19x	3.45x	4.36x	4.08x	4.05x	4.21x
Goodwill	1.99B	5.95B	4.52B	3.43B	3.4B	3.99B	3.98B	2.69B	2.44B	1.6B
Intangible Assets	600.7M	2.96B	2.83B	2.42B	2.18B	2.5B	2.32B	1.9B	1.71B	1.21B
Long-Term Investments	-160.3M	-848.6M	-718M	-552.8M	0	0	0	0	0	23M
Other Non-Current Assets	59.1M	64.1M	156.2M	76.8M	69M	95M	121M	198M	48M	278M
Total Assets+	4.4B	11.66B	10.38B	8.69B	8.6B	9.35B	9.24B	7.64B	7.37B	5.75B
Asset Turnover	0.61x	0.32x	0.38x	0.46x	0.47x	0.36x	0.46x	0.51x	0.54x	0.66x
Asset Growth %	-0.05%	1.65%	-0.11%	-0.16%	-0.01%	0.09%	-0.01%	-0.17%	-0.04%	-0.22%
Total Current Liabilities+	476M	771M	946.6M	1.01B	995M	1.37B	1.26B	1.17B	1.43B	1.59B
Accounts Payable	133.6M	223M	284.4M	283.9M	308M	302M	262M	279M	305M	241M
Days Payables Outstanding	42.14	46.66	57.51	54.01	60.51	65.5	50.76	56.73	59.25	47.94
Short-Term Debt	12.1M	21.1M	30.1M	92.4M	2M	299M	182M	118M	322M	549M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	166.9M	260.1M	353.3M	339.1M	128M	166M	212M	182M	458M	64M
Current Ratio	2.51x	2.44x	2.12x	1.86x	2.01x	1.31x	1.47x	1.62x	1.38x	1.10x
Quick Ratio	1.80x	1.77x	1.46x	1.27x	1.45x	0.96x	1.06x	1.08x	0.95x	0.74x
Cash Conversion Cycle	119.81	123.52	136.7	124.2	125.04	114.91	118.29	134.51	131.56	122.56
Total Non-Current Liabilities+	1.59B	2.76B	2.79B	2.54B	2.51B	3.04B	2.98B	2.66B	2.65B	2.22B
Long-Term Debt	1.14B	1.51B	1.61B	1.56B	1.43B	1.98B	1.91B	1.83B	1.8B	1.59B
Capital Lease Obligations	0	0	0	0	120M	130M	149M	149M	125M	91M
Deferred Tax Liabilities	160.3M	848.6M	718M	552.8M	480M	381M	391M	287M	0	129M
Other Non-Current Liabilities	446.5M	1.25B	1.18B	975.8M	480M	554M	528M	399M	730M	415M
Total Liabilities	2.06B	3.53B	3.74B	3.55B	3.51B	4.42B	4.24B	3.83B	4.08B	3.81B
Total Debt+	1.14B	1.51B	1.61B	1.66B	1.6B	2.46B	2.29B	2.15B	2.3B	2.27B
Net Debt	856.4M	1.13B	1.29B	1.35B	1.19B	2.02B	1.96B	1.78B	1.97B	2B
Debt / Equity	0.49x	0.19x	0.24x	0.32x	0.31x	0.50x	0.46x	0.56x	0.70x	1.17x
Debt / EBITDA	2.29x	2.08x	-	-	2.37x	7.42x	2.40x	-	8.91x	-
Net Debt / EBITDA	1.72x	1.55x	-	-	1.77x	6.09x	2.05x	-	7.62x	-
Interest Coverage	6.71x	12.67x	-41.39x	-25.69x	12.01x	-0.05x	9.97x	-14.42x	-1.05x	-12.74x
Total Equity+	2.34B	8.13B	6.64B	5.13B	5.09B	4.93B	5B	3.81B	3.29B	1.94B
Equity Growth %	0.01%	2.47%	-0.18%	-0.23%	-0.01%	-0.03%	0.01%	-0.24%	-0.14%	-0.41%
Book Value per Share	16.42	36.67	28.95	22.88	22.70	22.51	22.69	17.69	15.54	9.56
Total Shareholders' Equity	2.34B	8.11B	6.63B	5.12B	5.09B	4.93B	5B	3.81B	3.29B	1.94B
Common Stock	1.6M	2.6M	2.6M	2.6M	3M	3M	3M	3M	3M	3M
Retained Earnings	3.59B	3.95B	2.32B	1.23B	1.4B	1.2B	1.51B	456M	205M	-835M
Treasury Stock	-898.4M	-1.65B	-1.96B	-2.15B	-2.3B	-2.41B	-2.54B	-2.65B	-2.92B	-3.14B
Accumulated OCI	-594M	-705.7M	-291M	-478.7M	-600M	-464M	-592M	-628M	-636M	-730M
Minority Interest	1.4M	11.6M	11.6M	11.9M	2M	3M	1M	1M	1M	1M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	497.4M	563.4M	601.9M	499.8M	632.8M	649M	657M	517M	377M	461M
Operating CF Margin %	0.19%	0.15%	0.15%	0.13%	0.16%	0.19%	0.16%	0.13%	0.1%	0.12%
Operating CF Growth %	-0.11%	0.13%	0.07%	-0.17%	0.27%	0.03%	0.01%	-0.21%	-0.27%	0.22%
Net Income	251.1M	431.4M	-1.57B	-1.01B	263.1M	-73M	411M	-950M	-132M	-910M
Depreciation & Amortization	122.9M	271.7M	316.4M	330.8M	322.8M	334M	346M	328M	343M	349M
Stock-Based Compensation	25.6M	41.3M	48M	21M	66.2M	47M	48M	59M	46M	39M
Deferred Taxes	15.8M	-110.1M	-143.8M	-62M	-37.4M	-62M	-25M	-228M	-130M	-136M
Other Non-Cash Items	43.9M	-15M	2.08B	1.26B	50M	203M	3M	1.39B	339M	1.02B
Working Capital Changes	38.1M	-43.2M	-144.8M	-33.2M	-19.8M	200M	-126M	-78M	-89M	95M
Change in Receivables	-900K	-75.1M	-63.4M	23.5M	-91.4M	131M	-117M	85M	-58M	104M
Change in Inventory	32.1M	65.4M	-62.9M	-19.9M	13.7M	123M	-64M	-141M	6M	17M
Change in Payables	8.8M	7.2M	44.2M	7.1M	26.1M	-28M	-49M	30M	14M	-30M
Cash from Investing+	-54.9M	60M	-286.4M	-253.3M	-68.4M	-1.11B	-358M	-138M	-89M	-197M
Capital Expenditures	-72M	-126.1M	-151M	-188M	-122.9M	-87M	-142M	-149M	-149M	-180M
CapEx % of Revenue	0.03%	0.03%	0.04%	0.05%	0.03%	0.03%	0.03%	0.04%	0.04%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-105.8M	399.5M	-144.5M	-179.3M	-117M	1M	2M	-2M	47M	-17M
Cash from Financing+	-302.9M	-526.2M	-400.8M	-249.8M	-466.1M	476M	-379M	-329M	-307M	-302M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-40M	-64.6M	-78.3M	-78.6M	-80.9M	-88M	-92M	-104M	-116M	-126M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-33.4M	53.3M	82.3M	27.8M	75.6M	43M	15M	-15M	-10M	-16M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	425.4M	437.3M	450.9M	311.8M	509.9M	562M	515M	368M	228M	281M
FCF Margin %	0.16%	0.12%	0.11%	0.08%	0.13%	0.17%	0.12%	0.09%	0.06%	0.07%
FCF Growth %	-0.06%	0.03%	0.03%	-0.31%	0.64%	0.1%	-0.08%	-0.29%	-0.38%	0.23%
FCF per Share	2.99	1.97	1.97	1.39	2.27	2.56	2.34	1.71	1.08	1.38
FCF Conversion (FCF/Net Income)	1.98x	1.31x	-0.39x	-0.49x	2.47x	-8.89x	1.60x	-0.54x	-2.86x	-0.51x
Interest Paid	54.9M	36.7M	37M	35M	30M	45M	64M	70M	97M	91M
Taxes Paid	-71.4M	112.3M	122.7M	105M	112M	82M	148M	122M	177M	74M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.78%	8.22%	-20.99%	-17.17%	5.01%	-1.46%	8.28%	-21.57%	-3.72%	-34.75%
Return on Invested Capital (ROIC)	8.63%	5.48%	-13.84%	-9.97%	4.15%	-0.03%	6.56%	-11.2%	-1.17%	-14.33%
Gross Margin	56.73%	53.42%	54.8%	51.87%	53.8%	49.6%	55.47%	54.23%	52.61%	51.62%
Net Margin	9.39%	11.48%	-38.81%	-25.36%	6.37%	-2.19%	9.71%	-24.22%	-3.33%	-23.99%
Debt / Equity	0.49x	0.19x	0.24x	0.32x	0.31x	0.50x	0.46x	0.56x	0.70x	1.17x
Interest Coverage	6.71x	12.67x	-41.39x	-25.69x	12.01x	-0.05x	9.97x	-14.42x	-1.05x	-12.74x
FCF Conversion	1.98x	1.31x	-0.39x	-0.49x	2.47x	-8.89x	1.60x	-0.54x	-2.86x	-0.51x
Revenue Growth	-8.5%	40.05%	6.62%	-0.18%	0.9%	-16.98%	26.71%	-7.3%	1.1%	-4.34%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Technologies And Equipment	-	-	2.2B	2.14B	2.28B	1.96B	2.52B	2.32B	-	-
Technologies And Equipment Growth	-	-	-	-2.96%	6.91%	-14.11%	28.71%	-8.16%	-	-
Consumables	-	-	1.79B	1.85B	1.75B	1.38B	1.73B	1.6B	-	-
Consumables Growth	-	-	-	3.24%	-5.66%	-20.90%	25.05%	-7.12%	-	-
Dental Consumable Products	751.5M	1.77B	-	-	-	-	-	-	-	-
Dental Consumable Products Growth	-	135.57%	-	-	-	-	-	-	-	-
Dental Laboratory Products	333.7M	1.66B	-	-	-	-	-	-	-	-
Dental Laboratory Products Growth	-	397.03%	-	-	-	-	-	-	-	-
Dental Speciality Products	1.27B	316.4M	-	-	-	-	-	-	-	-
Dental Speciality Products Growth	-	-75.16%	-	-	-	-	-	-	-	-
Consumable medical device products	315.5M	-	-	-	-	-	-	-	-	-
Consumable medical device products Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Europe	-	-	-	-	1.61B	1.39B	1.69B	1.56B	1.55B	1.52B
Europe Growth	-	-	-	-	-	-14.06%	21.49%	-7.48%	-0.58%	-2.06%
UNITED STATES	1.03B	1.38B	1.38B	1.27B	1.37B	1.11B	1.5B	1.39B	1.44B	1.35B
UNITED STATES Growth	-	34.61%	-0.47%	-7.74%	8.12%	-19.23%	34.99%	-7.01%	3.23%	-6.19%
Other Foreign	-	-	-	-	1.04B	846M	1.07B	971M	978M	927M
Other Foreign Growth	-	-	-	-	-	-18.81%	26.36%	-9.17%	0.72%	-5.21%
GERMANY	472.8M	617M	493.3M	494.3M	-	-	-	-	-	-
GERMANY Growth	-	30.50%	-20.05%	0.20%	-	-	-	-	-	-
SWEDEN	42.3M	53.2M	52.4M	55.2M	-	-	-	-	-	-
SWEDEN Growth	-	25.77%	-1.50%	5.34%	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

DENTSPLY SIRONA Inc. (XRAY) reported $3.62B in revenue for fiscal year 2024. This represents a 43% increase from $2.54B in 2011.

DENTSPLY SIRONA Inc. (XRAY) saw revenue decline by 4.3% over the past year.

DENTSPLY SIRONA Inc. (XRAY) reported a net loss of $882.0M for fiscal year 2024.

Dividend & Returns

Yes, DENTSPLY SIRONA Inc. (XRAY) pays a dividend with a yield of 4.93%. This makes it attractive for income-focused investors.

DENTSPLY SIRONA Inc. (XRAY) has a return on equity (ROE) of -34.8%. Negative ROE indicates the company is unprofitable.

DENTSPLY SIRONA Inc. (XRAY) generated $80.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.